OHSU

Breast Cancer Survivors at Higher Risk for Falls; Cancer Therapies May Affect Balance, According to New Study in the Archives of Physical Medicine and Rehabilitation

03/04/11  St. Louis, MO

The combined effects of chemotherapy and endocrine therapy may increase the risk of bone fractures in breast cancer survivors.

In a study scheduled for publication in the April issue of the Archives of Physical Medicine and Rehabilitation, researchers from the Oregon Health & Science University Knight Cancer Institute, Portland, asked post-menopausal breast cancer survivors whether they had fallen in the past year and then tracked their falls over a six-month study period. They found evidence that women who have survived breast cancer may fall more often than their peers.


“Our study is the first to consider how breast cancer treatment may increase fall risk by using a Kerri Winterscomprehensive set of objective measures of fall risk and by exploring mediators of the treatment-falls relationship,” commented Kerri M. Winters-Stone, PhD, Associate Professor and Associate Scientist, Oregon Health & Science University, School of Nursing and a member of the Knight Cancer Institute. “Our findings suggest that recently treated postmenopausal breast cancer survivors have higher rates of falling compared with population averages for community-dwelling older adults. Balance disturbances may explain how treatment could have contributed to falls in breast cancer survivors.”

Investigators found that 58% of breast cancer survivors had experienced a fall in the previous year and almost half (47%) fell within 6 months after joining the study, a rate nearly double the 25% to 30% annual fall rate reported for community-dwelling older adults over 65 years of age.

Researchers measured a comprehensive set of neuromuscular and balance characteristics known to be associated with falls in 59 study participants. They found that only balance discriminated breast cancer survivors who fell from those who did not. The study findings also suggest that the balance problems may have been related to changes in the vestibular system that were associated with chemotherapy treatment.

Professor Winters-Stone stated, “Falls in breast cancer survivors are understudied and deserve more attention, particularly in light of the increase in fractures after breast cancer treatment and the relationship of falls to fractures. Our findings add to growing evidence that fall risk is increased in breast cancer survivors and that vestibular function may underpin associations between breast cancer treatment and falls.”

The article is “Identifying Factors Associated With Falls in Postmenopausal Breast Cancer Survivors: A Multi-Disciplinary Approach” by Kerri M. Winters-Stone, PhD, Britta Torgrimson, PhD, Fay Horak, PhD, PT, Alvin Eisner, PhD, Lillian Nail, PhD, RN, Michael C. Leo, PhD, Steve Chui, MD, and Shiuh-Wen Luoh, MD. It will appear in Archives of Physical Medicine and Rehabilitation, Volume 92, Issue 4 (April 2011), published by Elsevier. doi:10.1016/j.apmr.2010.10.039

# # #

 To schedule an interview with the authors please contact Elisa Williams at 503-494-4530 or willieli@ohsu.edu.

AUTHORS
Kerri M. Winters-Stone, PhD
Britta Torgrimson, PhD
Lillian Nail, PhD, RN
Michael C. Leo, PhD
School of Nursing, Oregon Health & Science University, Portland, OR

Fay Horak, PhD, PT
Alvin Eisner, PhD
Steve Chui, MD
School of Medicine, Oregon Health & Science University, Portland, OR

Shiuh-Wen Luoh, MD.
School of Medicine, Oregon Health & Science University, Portland, OR Portland Veterans Affairs Medical Center, Portland, OR

ABOUT THE ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

The journal publishes original articles that report on important trends and developments in physical medicine and rehabilitation and in the more interdisciplinary field of rehabilitation. Archives of Physical Medicine and Rehabilitation brings readers authoritative information on the therapeutic utilization of physical and pharmaceutical agents in providing comprehensive care for persons with disabilities and chronically ill individuals. Archives began publication in 1920, publishes monthly, and is the official journal of the American Congress of Rehabilitation Medicine. Its papers are cited more often than any other rehabilitation journal. www.archives-pmr.org



ABOUT THE AMERICAN CONGRESS OF REHABILITATION MEDICINE

The American Congress of Rehabilitation Medicine serves people with disabling conditions by promoting rehabilitation research and facilitating information dissemination and the transfer of technology. We value rehabilitation research that promotes health, independence, productivity, and quality of life for people with disabling conditions. We are committed to research that is relevant to consumers, educates providers to deliver best practices, and supports advocacy efforts that ensure adequate public funding for our research endeavors. www.acrm.org


ABOUT ELSEVIER
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (www.thelancet.com) and Cell (www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include SciVerse ScienceDirect (www.sciencedirect.com), SciVerse Scopus (www.scopus.com), Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and Nursing Consult (www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (www.scival.com) and MEDai’s Pinpoint Review (www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).